AERAS [to 18 June 2016]
http://www.aeras.org/pressreleases

.
May 23, 2016
Aeras Provides Update on Phase 2 Trial (C-040-404/TUB09) of H4:IC31
Rockville, MD,– The Sanofi Pasteur-Aeras Joint Steering Committee for the Phase 2 trial (C-040-404/TUB09) convened on 14 June 2016 to review and discuss the recommendations of the study’s independent Data Monitoring Committee (DMC).

The DMC, which met on 02 June 2016, reviewed unblinded safety and efficacy data and concluded that the trial had been well conducted to date and that the data was of good quality. There were no safety concerns of note. The DMC recommends that follow-up be continued as per protocol with a further DMC review close to the end of follow-up…